Letter to the editor: no increased febrile neutropenia risk to cancer patients receiving lipegfilgrastim—correction of a systematic review and meta-analysis of randomized controlled trials with G-CSF

Saved in:
Bibliographic Details
Published in:Supportive care in cancer 2016-05, Vol.24 (5), p.1935-1937
Main Authors: Lehmacher, W., Klasser, M., Duering, A.
Format: Article
Language:English
Subjects:
Cancer patients
Febrile Neutropenia - prevention & control
Female
Filgrastim - therapeutic use
Granulocyte Colony-Stimulating Factor - therapeutic use
Health aspects
Humans
Letter to the Editor
Lymphoma, Non-Hodgkin - drug therapy
Medicine
Medicine & Public Health
Neutropenia
Nursing
Nursing Research
Oncology
Pain Medicine
Primary Prevention
Rehabilitation Medicine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0941-4355
1433-7339
DOI:10.1007/s00520-016-3116-3